Firms

Johnson & Johnson Innovation – JJDC

Johnson & Johnson Innovation – JJDC

jnjinnovation.com

Johnson & Johnson Innovation – JJDC, Inc. is Johnson & Johnson’s corporate venture capital organization. It invests across company stages in biotechnology and medical technology, providing financing, company-building support and access to the parent group’s scientific and commercial capabilities. Its biotech focus includes neuropsychiatry, neurodegeneration, ophthalmology, oncology and immunology. Its MedTech focus spans neurovascular care, surgical technologies, digital systems and robotics, orthopaedics and vision. Its published holdings include neurodegenerative gene therapy developer AviadoBio, brain autoantibody therapeutics developer Arialys, targeted protein degrader company Prazer and AI cancer testing platform Artera. JJDC is the specific corporate venture capital entity, distinct from Johnson & Johnson Innovation’s broader partnering and JLABS incubation activities.

Founded
—
Type
Venture capital

Funds0

No funds on record yet.

Team

Operations and support

Amir BlattAmir BlattPrincipal, Venture Investments
Andres TellezAndres TellezPrincipal, New Company Creation
Asish XavierAsish XavierVice President, Venture Investments
Biren MehtaBiren MehtaVice President, Venture Investments
Chris PicarielloChris PicarielloPresident, JJDC
Edna LazarEdna LazarPrincipal, Venture Investments
Fiona MacLaughlinFiona MacLaughlinVice President, Venture Investments
Gilad GlickGilad GlickVice President, Venture Investments
Hirak ParikhHirak ParikhPrincipal, Venture Investments
Kyle O’NeilKyle O’NeilAnalyst, Venture Investments
Lior TeitelbaumLior TeitelbaumPrincipal, Venture Investments
Nadiya IshnazarovaNadiya IshnazarovaPrincipal, Venture Investments
Nancy OndovikNancy OndovikPrincipal, New Company Creation
Rahul RakhitRahul RakhitAnalyst, Venture Investments
Sanjay MistrySanjay MistryVice President, Venture Investments, New Company Creation
Shany SteinmetzShany SteinmetzAnalyst, Venture Investments
Tamir MeiriTamir MeiriPrincipal, Venture Investments
V. Kadir KadhiresanV. Kadir KadhiresanVice President, Venture Investments
Wei WuWei WuPrincipal, Venture Investments

Co-investing

Alexandria Venture Investments
Eli Lilly and Company
Pfizer Ventures
Polaris Partners
SV Health Investors

Investments

$50M2026-01-27TRexBioEli Lilly and Company, SV Health Investors, Johnson & Johnson Innovation – JJDC, Pfizer Ventures, Alexandria Venture Investments, Polaris Partners, Delos Capital, Avego BioScience Capital, Janus Henderson Investors
$84M2024-11-13TRexBioDelos Capital, Eli Lilly and Company, SV Health Investors, Johnson & Johnson Innovation – JJDC, Pfizer Ventures, Alexandria Venture Investments, Polaris Partners, Avego BioScience Capital, Agent Capital
$58M2023-09-12Arialys TherapeuticsJohnson & Johnson Innovation – JJDC, Alexandria Venture Investments, Avalon BioVentures, Catalys Pacific, MPM BioImpact
$85M2022-03-08TRexBioEli Lilly and Company, SV Health Investors, Johnson & Johnson Innovation – JJDC, Pfizer Ventures, Alexandria Venture Investments, Polaris Partners, Laurion Capital Management
$80M2021-12-02AviadoBioNew Enterprise Associates, Monograph Capital, Advent Life Sciences, Dementia Discovery Fund, F-Prime Capital, LifeArc Ventures, EQT Life Sciences, Johnson & Johnson Innovation – JJDC
$16MUnknown dateAviadoBioAdvent Life Sciences, Dementia Discovery Fund, F-Prime Capital, LifeArc Ventures, Johnson & Johnson Innovation – JJDC